Robert Lustig: fructose inhibits three important enzymes in the liver #obesogens #doctors #doctors
Short excerpt from a lecture by Robert Lustig (uploaded by Dr. Ron Najafi) arguing that dietary fructose inhibits key liver enzymes (AMP kinase, acadL/ACADL, and CPT1A), thereby reducing mitochondrial beta-oxidation and acting as a ‘mitochondrial toxin’. The speaker contrasts fructose’s inhibitory effects with glucose’s activation of enzymes that promote beta-oxidation.
Chapters
More from Dr.
Hippocrates said, let thy food be thy medicine #obesity #metabolicsyndrome #lustig #shorts #health
Bill Wilson, MD: Why GLP-1 Drugs Are Overpriced—and How Compounding and Competition Could Fix It
Nitrosamine in Pharmaceutical Products? A Deep Dive into Risk Management by Ron Najafi, Ph.D.
The Subcellular Processes That Belie All Chronic Disease. The Hateful (or Grateful) Eight #lustig
Bill Wilson, MD: GLPs May Reverse Carb Syndrome—Helping Patients Reach Zero and Sustain with Diet
Why Everything You Knew About Obesity Is Wrong | Dr. Robert Lustig on Sugar & Metabolic Syndrome
Robert Lustig, MD: How Fructose Fuels Fatty Liver, Oxidative Stress, and Metabolic Disease #fructose
Robert Lustig, MD: The 3 Types of Fat Fueling Insulin Resistance and Disease #insulin resistance
Bill Wilson, MD: GLPs May Reverse CARB Syndrome. Helping Patients Reach Zero and Sustain with Diet